Latest Market News

Orthocell has initiated commercial sales of its Remplir nerve repair device in Canada, leveraging a distributor-led model to penetrate a US$75 million market and setting the stage for broader North American expansion.

Dimerix has completed adult patient recruitment in its Phase 3 ACTION3 trial for DMX-200, with a blinded review confirming the study remains statistically powered to demonstrate treatment efficacy. The company also appointed a new CFO and is negotiating up to US$50 million in non-dilutive funding.

Godolphin Resources has raised A$2.5 million through a discounted share placement to fund a 2,500m diamond drilling program and metallurgical test work at its Lewis Ponds project, aiming to expand its JORC resource and advance development.

Electro Optic Systems (ASX: EOS) reported a 13% increase in contract backlog to A$518 million in Q1 2026, driven by multiple major defence orders and the opening of a new Singapore facility. The company’s cash position remains strong despite a $4 million ASIC penalty.

Microba Life Sciences reported a 99% year-on-year surge in core testing revenue for Q3 FY26, propelled by strong test volume growth and new clinic contracts in Australia and the UK. The company is advancing a major product release and negotiating a significant corporate transaction to bolster its financial position.

Blackstone Minerals has cleared a key regulatory hurdle at its Mankayan Copper-Gold Project, lifting a Cease and Desist Order and initiating a Pre-Feasibility Study. The company also strengthened its board with mining veteran Mark Williams and reported a solid cash position of $14.6 million.

Ioneer Ltd has raised US$50 million to push forward its fully permitted Rhyolite Ridge lithium-boron project in Nevada, buoyed by a federal court ruling upholding project approvals and ongoing strategic partner discussions.

Liontown Limited delivered its strongest financial quarter since production began, achieving a self-funded quarter with a $33 million cash boost and surpassing underground mining targets ahead of schedule, while maintaining FY2026 guidance amid robust lithium market conditions.

D3 Energy has significantly expanded its South African helium footprint with new Exploration Rights and a Technical Cooperation Permit, while completing a well-supported A$6.12 million placement to fund upcoming drilling and development activities.

Sarytogan Graphite Limited has received $1.4 million from the European Bank for Reconstruction and Development, boosting funds for its Definitive Feasibility Study and advancing its strategic graphite project in Kazakhstan.

Yugo Metals (ASX:YUG) secured government approval for its Petrovo tenement in Bosnia, while initial drilling at Sinjakovo’s Kovacevac and Erak prospects delivered promising polymetallic results. The company also appointed Petar Tomašević as permanent CEO, positioning itself for further exploration progress.

Percheron Therapeutics has secured $2.2 million through an entitlement offer to fund the next stage of its HMBD-002 oncology program, with manufacturing underway and key data presentations lined up at major cancer conferences.